Baseline characteristics
| Baseline characteristics | |
| Age (years) | 65.47±10.3 |
| BMI (kg/m2) | 28.06±4.17 |
| Sex (female) (n/%) | 53/75.70 |
| Hypertension (n/%) | 38/56.20 |
| Diabetes (n/%) | 9/12.3 |
| Glomerular filtration rate (mL/min/m2) | 72.81/–18.45 |
| COPD (n/%) | 12/17.40 |
| Dyslipidaemia (n/%) | 30/43.80 |
| Cardiovascular history | |
| Left heart failure (n/%) | 30/42.80 |
| Right heart failure (n/%) | 32/46.40 |
| Preoperative atrial fibrillation (n/%) | 55/79.50 |
| Coronary heart disease (n/%) | 6/8.6 |
| Stroke (n/%) | 9/12.8 |
| SPAP (mm Hg) | 52.45±15.96 |
| LVEF (n/%) | |
| >52% in males or >54% in females | 56/80.0 |
| 41%–51/53% (males/females) | 10/14.2 |
| 30%–40% | 3/4.2 |
| <30% | 1/1.4 |
| RVEF (%) | |
| TAPSE >17 mm | 57/81.4 |
| 15–17 mm | 10/14.2 |
| <15 mm | 3/4.2 |
| Surgical variables | |
| Previous cardiac surgery (n/%) | 20/28.5 |
| Mean EuroSCORE (%) | 5±3.66 |
| Extracorporeal time (min) | 112±39.3 |
| Clamping time (min) | 83.42±46.71 |
| TR aetiology (n/%) | |
| Functional | 49/69.9 |
| Rheumatic | 14/20.5 |
| Myxomatous | 2/2.7 |
| Pacemaker mediated | 1/1.4 |
| Radiation mediated | 1/1.4 |
| Unspecified | 3/4.1 |
| Grade of TR (n/%) | |
| Mild | 7/10 |
| Moderate | 25/35.7 |
| Moderate-severe | 7/10 |
| Severe | 31/44.28 |
| Type of valve surgery (n/%) | |
| Tricuspid alone | 17/24.7 |
| Tricuspid+Mitral | 30/42.5 |
| Tricuspid+aortic | 2/2.7 |
| Trivalvular | 14/20.5 |
| Other type | 7/9.6 |
BMI, body mass index; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; RVEF, right ventricular ejection fraction; SPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation; TV, tricuspid valve.